🔥 Bitget US Stock Hotspot Sniper｜2026.08.26 Main Theme: AI Validation Window Opens｜Nvidia Earnings · Chip Rebound · Optical Modules · Space Infrastructure

1. Nvidia Earnings Tonight – Critical Test for AI Sentiment
   NVDA rose 2.19% yesterday, ending a seven-day losing streak, as the market awaits after-hours results for fiscal Q2 2027. Key focuses include data center revenue, gross margins, Rubin platform shipment progress, and guidance on hyperscaler capex. The prior sell-off already reflected concerns over the sustainability of AI spending.
   🎯 Beneficiaries: NVDA, SMCI, AVGO; Key Catalyst: Earnings and guidance will directly validate the strength of the current AI hardware trade; after-hours volatility expected to expand.
2. AMD Upgraded – Agentic AI Drives New CPU Narrative
   Raymond James upgraded AMD to Strong Buy with a price target of $641, highlighting that Agentic AI workloads will significantly boost server CPU demand, with the related market projected to reach $201 billion by 2030. AMD surged nearly 5% yesterday, leading the Philadelphia Semiconductor Index.
   🎯 Beneficiaries: AMD, INTC, MU; Key Catalyst: Analyst framework expands to the CPU layer, short-term capital rotating back into non-GPU chips.
3. Optical Communications Buying Returns – LITE & COHR Lead Gains
   Demand for high-speed interconnects in AI data centers reaccelerated. Lumentum rose over 6.6% and Coherent over 4.6% yesterday. Both are key photonics partners of Nvidia and stand to benefit from the ramp of 1.6T optical modules and laser capacity expansion.
   🎯 Beneficiaries: LITE, COHR, CIEN; Key Catalyst: Optical module sector pre-positioning ahead of earnings; watch capacity delivery progress.
4. SpaceX Announces $100 Billion Louisiana Launch Site
   SpaceX unveiled plans to invest up to $100 billion in Starbase Louisiana, aiming to build the world’s largest launch site capable of supporting thousands of Starship flights annually. Construction is expected to begin in 2027.
   🎯 Beneficiaries: RKLB and related aerospace supply chain; Key Catalyst: Space infrastructure and orbital compute narrative heating up; clear event-driven catalyst.
5. Moderna Cancer Vaccine Narrative Continues to Build
   Following the successful Phase 3 trial of its personalized mRNA cancer vaccine co-developed with Merck, multiple institutions raised price targets. MRNA surged over 14% again yesterday, lifting biotech sentiment.
   🎯 Beneficiaries: MRNA, MRK; Key Catalyst: Commercialization outlook further confirmed; capital rotating back into innovative drugs.

Trading Note: Today’s focus is Nvidia earnings and PCE data. Chips and optical modules have already rebounded; capital is flowing toward AI validation. Lower oil prices and declining Treasury yields provide macro support, but volatility remains elevated — manage position sizes carefully.
US equities have seen heightened volatility recently. The above content is for informational reference only and does not constitute investment advice.